For much of the year, WorldNetDaily has run a series called “America First Immigration,” designed to scare readers into believing that an army of swarthy foreigners are coming for American jobs. Typical of the scare tactics is an Oct. 21 article by Amanda Bartolotta:
It’s every parent’s nightmare: Racing their child to the emergency room, only to learn that the cough syrup they gave their son or daughter, rather than relieving their cough, instead had poisoned their child. It’s the kind of horror story no one expects, especially from something made for children. Yet it accurately reflects a grim reality of today’s global pharmaceutical trade.
In this case, a drug manufacturer in India decided to swap safe ingredients for cheaper, toxic chemicals, the same substances used in engine coolant, brake fluid and antifreeze. As horrifying as that story sounds, there’s an even more unsettling truth: The same country responsible for those deadly syrups also produces a huge share of the medicines sitting in American homes and hospitals.
India now dominates the global generic drug market, supplying the majority of the low-cost prescriptions Americans take every day.
Behind that dominance lies a disturbing pattern of fraud, contamination and neglect. Factories caught falsifying test results, skipping safety checks or cutting corners with unsafe inputs have continued shipping products abroad with little interruption – and even less accountability.
For American families, that means the same system that poisoned children overseas is the one filling pharmacy shelves across the United States, a system propped up by loopholes, blind trust and an unhealthy dependence on foreign supply chains that prize volume and profit over human life.
Bartolotta’s goal is to fearmonger, not spread reliable information, as this passage demonstrates (boldface is hers):
Since 2000, pharmaceutical imports have surged to unprecedented levels: By 2024, the U.S. brought in more than 828,000 metric tons of drugs and ingredients, over seven times the volume imported at the start of the century.
This surge is not about higher medical needs. It is the product of a failed trade and regulatory model that has sacrificed American manufacturing for short-term profits and cheaper foreign supply with higher risk. The result is a $118 billion pharmaceutical trade deficit in 2024 and the steady erosion of national control over one of America’s most vital industries.
The United States, once the global leader in medical innovation and quality, now relies on foreign powers to make its citizens’ medicines.
Two countries, China and India, dominate the American drug supply. Together they account for 70 to 80 percent of the generics and key ingredients in U.S. medicine cabinets. India alone produces nearly half of all finished generics sold in this country, while China supplies many of the raw compounds used to make them. This dependency doesn’t just threaten America’s health; it hands foreign governments and corporations enormous leverage over U.S. national security.
Indeed, Bartolotta’s solutioin to this so-called crisis is for the U.S. to take over India’s pharmaceutial industry:
Rebuilding domestic pharmaceutical production isn’t just sound and necessary economic policy; it’s national security. Closing the $118.3 billion pharmaceutical trade deficit would not only create jobs, it would restore accountability to an industry that should never have been outsourced in the first place.
If America is serious about protecting its citizens’ health, it must reclaim control of its own medicine supply. In the era of MAHA – “Make America Healthy Again” – perhaps the first step is ending dependence on foreign manufacturers whose repeated failures are making many people sicker – not better.
The article concluded with an “IMPORTANT NOTE”:
IMPORTANT NOTE: Key members of Congress, as well as the Trump administration itself – including the office of the vice president and the Department of Justice – are all well aware of, and taking serious note of, WND investigative reporter Amanda Bartolotta’s groundbreaking reporting on the widespread corruption, fraud and abuse involving America’s immigration and trade policies – centering largely on the nation of India.
That tells you all you need to know about this — it’s more an effort to fix WND’s lengthy history of journalistic malpractice than trying to impart credible information.